The increasing challenge regarding pediculosis capitis – more commonly referred to as head lice – is being exacerbated by the common development immunity to standard treatments. Thankfully, scientists are unveiling promising approaches to address these stubborn infestations. Emerging therapies feature targeted products which uniquely inactivate